Arbeitspapier

How Do Drug Prices Respond to a Change from External to Internal Reference Pricing? Evidence from a Danish Regulatory Reform

We study the effects of a change in the way patient reimbursements are calculated on the prices of pharmaceuticals using quasi-experimental data for Denmark which switched from external (where reimbursements are based on prices of similar products in foreign countries) to internal reference pricing (where they are based on the cheapest domestic substitute). We analyze three therapeutic classes with different treatment durations and show that the reform led to substantial price decreases for our lifelong treatment and to less substantial price reductions for our medium duration treatment while we do not find significant effects on our acute treatment. Moreover, the reform did only affect generics and did not impact original products or parallel imports.

Language
Englisch

Bibliographic citation
Series: IZA Discussion Papers ; No. 8759

Classification
Wirtschaft
Health: Government Policy; Regulation; Public Health
Single Equation Models; Single Variables: Panel Data Models; Spatio-temporal Models
Subject
pharmaceutical markets
regulation
reference pricing
treatment duration

Event
Geistige Schöpfung
(who)
Kaiser, Ulrich
Méndez, Susan J.
Event
Veröffentlichung
(who)
Institute for the Study of Labor (IZA)
(where)
Bonn
(when)
2015

Handle
Last update
10.03.2025, 11:44 AM CET

Data provider

This object is provided by:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.

Object type

  • Arbeitspapier

Associated

  • Kaiser, Ulrich
  • Méndez, Susan J.
  • Institute for the Study of Labor (IZA)

Time of origin

  • 2015

Other Objects (12)